Simultaneous determination of amoxicillin and clavulanic acid in pharmaceutical preparations by capillary zone electrophoresis by Hancu, Gabriel et al.
*Correspondence: Gabriel Hancu. Faculty of Pharmacy. University of 
Medicine and Pharmacy. TîrguMureş, Gh. Marinescu 38, 540139 - TîrguMureş, 
Romania. E-mail: g_hancu@yahoo.com, gabriel.hancu@umftgm.ro
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 52, n. 2, apr./jun., 2016
http://dx.doi.org/10.1590/S1984-82502016000200006
Simultaneous determination of amoxicillin and clavulanic acid in 
pharmaceutical preparations by capillary zone electrophoresis
Gabriel Hancu1,*, Anamaria Neacşu1, Lajos Attila Papp1, Adriana Ciurba2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy, TîrguMureş, 
Romania, 2Department of PharmaceuticalTechnology, Faculty of Pharmacy, University of Medicine and Pharmacy, Tîrgu 
Mureş, Romania
Clavulanic acid enhances the antibacterial spectrum of amoxicillin by rendering most β-lactamase 
producing isolates susceptible to the drug. A fast, simple and efficient capillary electrophoresis method 
was developed for the simultaneous determination of amoxicillin and clavulanic acid from complex 
mixtures. Using a 25 mM sodium tetraborate as background electrolyte at a pH of 9.30, + 25 kV 
applied voltage, 25 °C system temperature, UV determination at 230 nm; we succeeded in simultaneous 
separation of amoxicillin and clavulanic acid in approximately 2 minutes. The analytical performance of 
the method was evaluated in terms of reproducibility, precision, accuracy, and linearity. The optimized 
analytical method was applied for the determination of the two analytes from combined commercial 
pharmaceutical preparations. This CE method is fast, inexpensive, efficient, and environmentally friendly 
when compared with the more frequently used high performance liquid chromatography methods 
described in the literature.
Uniterms: Amoxicillin/determination. Clavulanic acid/determination. Capillary electrophoresis/
quantitative analysis. Antibacterials/quantitative analysis.
O ácido clavulânico acentua o espectro antibacteriano de amoxicilina, tornando a maioria dos isolados 
produtores de β-lactamase sensíveis ao fármaco. Desenvolveu-se um método rápido, simples e eficiente 
de electroforese capilar (EC) para a determinação simultânea de amoxicilina e de ácido clavulânico a 
partir de misturas complexas. Usando tetraborato de sódio 25 mM como electrólito em pH de 9,30, 
voltagem aplicada de + 25 kV, em sistema a 25 ° C e determinação por UV a 230 nm, a foi bem-sucedida a 
separação simultânea de amoxicilina e ácido clavulânico em, aproximadamente, 2 minutos. O desempenho 
analítico do método foi avaliado em termos de reprodutibilidade, precisão, exatidão e linearidade. O 
método analítico otimizado foi aplicado para a determinação dos dois analitos em associação, a partir de 
preparações farmacêuticas comerciais. Este método de EC é rápido, barato, eficiente e ecologicamente 
correto, quando comparado aos métodos de cromatografia líquida de alta eficiência mais frequentemente 
descritos na literatura.
Unitermos: Amoxicilina/determinação. Acido clavulânico/determinação. Eletroforese capilar/análise 
quantitativa. Antibacterianos/análise quantitativa.
G. Hancu, A. Neacşu, L. A. Papp, A. Ciurba282
INTRODUCTION
Amoxicillin (AMX), (2S,5R,6R)-6-{[(2R)-2-amino-
2-(4-hydroxyphenyl)-acetyl]amino}-3,3-dimethyl-7-
oxo-4-thia-1-azabicyclo[3.2.0]heptane-24-carboxylic 
acid, is a β-lactam semisynthetic penicillin from the 
aminopenicillin class with a broad antibacterial spectrum, 
used to treat a large number of infections with susceptible 
Gram-positive and Gram-negative bacteria. It is one of the 
most frequently prescribed penicillin derivatives within 
the class because it is better absorbed, following oral 
administration, than other β-lactam antibiotics (Block, 
Beale, 2011).
AMX is susceptible to degradation by β-lactamase 
producing bacteria, which are resistant to a narrow 
spectrum of β-lactam antibiotics, such as natural 
penicillins. For this reason, it is often combined with 
clavulanic acid, a β-lactamase inhibitor.
C lavu lan ic  ac id  (CLA) ,  (2R , 5R ,S ) -3 - (2 -
hydroxyethylidene)-7-oxo-4-oxa-1-aza-bicyclo[3.2.0]
heptane-2-carboxylic acid, is an oxapenam derivative 
lacking the 6-acylamino side chain characteristic 
for penicillin derivatives, which exhibits very weak 
antibacterial activity, and, therefore, is not useful as an 
antibiotic. It is used combined with penicillin group 
antibiotics to overcome resistance to bacteria that 
secrete β-lactamase. CLA can be described as a “suicide 
inhibitor”, covalently bonding to a serine residue in the 
active site of the β-lactamase (Block, Beale, 2011).
Combining these two drugs increases effectiveness 
by reducing susceptibility to β-lactamase resistance. 
Combinations of AMX trihydrate and the potassium salt 
of CLA are available in various fixed-doses of oral and 
injectable dosage forms intended for the treatment of 
skin, respiratory, ear, and urinary tract infections caused 
by β-lactamase producing bacterial strains (Block, Beale, 
2011; Todd, Benfield, 1990).
The chemical structures of AMX and CLA are 
presented in Figure 1.
Taking into consideration the fact that the 
combination AMX – CLA is frequently prescribed for 
many infections caused by susceptible bacteria, the 
development of new modern analytical methods for the 
simultaneous determination of the two substances is 
a permanent necessity and also due to their particular 
physicochemical and structural characteristics, a 
challenge.
Usually, high performance liquid chromatographic 
(HPLC) methods are used for the simultaneous 
determination of the two substances from pharmaceutical 
products (Tai-Li et al., 1997; Aghazedeh, Kazemifard, 
2001; Pajchel, Pawlowski, Tyski, 2002) and human 
plasma (Hoizey et al., 2002; Kyung-Hwan et al., 2004; 
Foroutan et al., 2007), using different special techniques 
such β-cyclodextrin as stationary phase (Tai-Li et al., 
1997), reversed phase RP – HPLC (Foroutan et al., 
2007), HPLC - electrospray ionization (ESI) - mass 
spectrometry (MS) (Kyung-Hwan et al., 2004), with 
amperometric detection (Aghazedeh, Kazemifard, 2001) 
or UV detection (Pajchel, Pawlowski, Tyski, 2002; 
Hoizey et al., 2002).
Simultaneous determination of these compounds 
in complex preparations have also been carried out by 
UV spectrophotometric measurements using 1st order 
derivative spectrophotometry (Abdel-Moety et al., 1999; 
Bobrowska-Grzesik, 2001).
Surprisingly, only one capillary electrophoresis 
(CE) method with UV detection has been reported in 
the literature for the simultaneous determination of 
AMX and CLA, as Pajchel, Pawlowski and Tyski (2002)
developed a comparative study between CE and LC for 
simultaneous determination of amoxicillin/clavulanic acid 
and ampicillin/sulbactam in pharmaceutical formulations 
for injections. This latter method uses a phosphate–borate 
buffer containing 14.4% sodium dodecyl sulfate at pH 8.6 
() for the separation.
Nevertheless, CE is frequently used in the 
quantitative and qualitative determinations of different 
β-lactam antibiotics being considered today a useful 
alternative and also a complementary technique to the 
more frequently used HPLC methods (Garcia-Ruiz, 
Marina, 2006; Baillon-Perez et al., 2009; Garcia-Campana 
et al., 2009).
Our aim was the development of a new alternative 
CE method for the simultaneous separation of AMX and 
CLA, the optimization of the electrophoretic parameters 
and also to verify the applicability of the newly developed 
method in the determination of the two β-lactam 
derivatives from pharmaceutical preparations.
FIGURE 1 - Chemical structures of AMX and CLA.
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MATERIAL AND METHOD
Instrumentation
CE determinations were performed on an Agilent 
7100 CE system (Agilent, Waldbronn, Germany) 
equipped with a DAD detector. Data were collected 
using Chemstation 7.01 (Agilent, Waldbronn, Germany) 
software. Separations were performed using a short 
28 cm length (20 cm effective length) x 50 μm I.D 
silica-fused capillary (Agilent, Waldbronn, Germany). 
pH measurements were performed on a Terminal 740 
pH meter (Inolab, Germany). In order to establish the 
optimum wavelength for the CE determination, we 
previously recorded the UV spectrum of the two substances 
using a Specord 210 UV-VIS spectrophotometer (Analytik 
Jena, Germany).
Chemicals and reagents
Amoxicillin trihydrate and potassium clavulanate 
were supplied by Antibiotice (Iaşi, Romania). All reagents: 
methanol, sodiumtetraborate, sodiumhydroxide (Merck, 
Darmstadt, Germany) were of analytical grade. Purified 
water was provided by a Milli-Q Plus water purification 
system (Millipore, USA).
For  t he  de t e rmina t ion  f rom commerc i a l 
pharmaceutical preparations we used Augmentin® tablets 
(Glaxo Wellcome, UK) each tablet containing 500 mg 
AMX and 125 mg CLA, obtained from a local pharmacy.
Sample preparation
Standard stock solutions of the analytes in a 
concentration of 1 mg mL-1 were prepared in water and 
later diluted to the appropiate concentration. All samples 
and buffers were filtered through a 0.45 μm syringe filter 
and degassed by ultrasound for 5 minutes before use. 
The electrophoretic runs were performed as quickly as 
possible, due to the instability of β-lactams in solution. 
The samples were introduced in the system at the anodic 
end of the capillary by hydrodynamic injection.
For the analysis of pharmaceutical preparations 
10 Augmentin® tablets were weighed accurately and 
the average mass of one tablet was calculated. Tablets 
were pulverized and an average weight of a single tablet, 
equivalent to 500 mg amoxycillin and 125 mg clavulanic 
acid was weighed, transferred to a 100 mL volumetric 
flask and diluted with water to the mark. The content of the 
flask was ultrasonicated for 10 minutes, and the solution 
was filtered through a 0.45 μm syringe filter. 1 mL filtrate 
was transferred to a 10 mL flask and diluted with water to 
the mark. The samples were diluted with water to suitable 
concentrations.
Synthetic mixtures were also prepared by adding 
125 mg potassium clavulanate to 500 mg amoxycillin 
trihydrate, the mixture was weighed and dissolved in a 
100 mL volumetric flask with water. After shaking and 
filtration, 1 mL filtrate was transferred to a 10 mL flask and 
diluted with water to the mark; the final injected amounts 
of AMX and CLA were equivalent to ratio of 4:1.
Electrophoretic procedure
The capillary was washed at the beginning of the day 
with 0.1 M sodium hydroxide for 5 minutes followed by a 
water wash for another 5 minutes. Before every analysis 
the capillary was washed for 2 minutes with the running 
buffer.
In the preliminary analysis we applied some 
“standard” electrophoretic conditions for a CE analysis: 
temperature 20 ˚C, applied voltage + 25 kV, injection 
pressure/time 50 mbar/3 sec, sample concentration 
10 μg mL-1. The detection wavelengths were set to 210 
and 230 nm, respectively.
RESULTS AND DISCUSSION
Optimization of the analytical procedure
For the separat ion,  we chose the simplest 
electrophoretic technique, capillary zone electrophoresis 
(CZE). In CZE, the separation mechanism is based on 
differences in the charge-to-mass ratio of the analytes.
An important consideration in the selection of 
optimum electrophoretic conditions was obtained by 
consulting the ionization constants and also the structural 
characteristics of the analytes. AMX has two pKa 
values; 2.8 corresponding to the – COOH group and 7.3 
corresponding to the – NH2 substituent; and consequently 
can be detected in both acid and alkaline environments; 
while CLA exhibits only one pKa value 2.6 corresponding 
to the – COOH group, and consequently will ionizes 
only in an alkaline environment. Therefore, for the 
simultaneous separation of AMX and CLA, we chose an 
alkaline buffer containing sodium tetraborate.
Our aim was not only the development of an efficient 
method for the determination of the two analytes, but also 
the pursuit of a systematic study regarding the influence 
of different analytic and electrophoretic parameters on the 
separation process. Efforts were focused on the optimization 
of the different analytical conditions (effects of buffer 
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concentration and pH, the presence of possible buffer 
modifiers) and electrophoretic parameters (applied voltage, 
system temperature, injection parameters), in order to obtain 
increased resolutions and short analysis times.
An increase in buffer concentration modified only on 
the migration times of the analytes, but had only a slight 
effect on the resolution of the separation. The higher the 
buffer concentration, the later the migration time of the 
analytes, because increasing the concentration of the 
electrolyte decreases the electroosmotic flow (EOF). The 
optimum buffer concentration was set to 25 mM.
The pH of the buffer is the main factor affecting 
resolution. The pH was adjusted by adding 0.1M NaOH 
solutions to the original buffer solution. Migration times 
had the tendency to increase at high pH values, but the 
resolution became poor. The optimum pH value for the 
separation was set to 9.30.
Electrophoretic velocities of the analytes are directly 
proportional to field strength, so the use of high voltages 
will result in shorter analysis time, the limiting factor being 
the Joule heating, which can cause the destabilization of 
the electrophoretic system. As temperature increases, 
the viscosity of the electrolyte decreases, thus the 
electrophoretic mobility of the analytes increases as 
well. The optimum voltage was set to +25 kV while the 
optimum temperature was set to 25 °C, in order to obtain 
good resolutions and a short analysis times.
The injection parameters influence mainly the shape 
and amplitude of the peaks, consequently, a high injection 
pressure of 50 mbar and a short injection time of 1 second 
provided a reasonable sample load and maintained 
resolution.
Using buffer solution containing 25 mM sodium 
tetraborate, at a pH of 9.3, applying a voltage of +25 kV 
at a temperature of 25 °C, we achieved the simultaneous 
separation of the studied analytes in less than 2 minutes, 
the order of separation being: AMX followed by CLA 
(Figure 2).
Although the stability of β-lactam antibiotics in 
the solid state is usually satisfactory, on dissolution in 
water they are slowly hydrolyzed to different degradation 
products. Our preliminary studies using an internal 
standard (ciprofloxacin hydrochloride) as reference 
showed that within 24 hours of dissolution degradation 
(hydrolysis) of the two analytes was insignificant.
Analytical performances
The analytical performance of the method was 
evaluated in terms of reproducibility, precision, robustness, 
accuracy and linearity. The previously optimized 
CZE separation parameters were used for all these 
measurements.
As internal standard (IS) we used a fluoroquinolone 
derivative, ciprofloxacin hydrochloride; a zwitterionic 
compound (containing both acidic and basic groups), 
which can ionize in both acidic and alkaline environments. 
Ciprofloxacin exhibits a smaller electrophoretic mobility 
than the two β-lactam derivatives, and will migrate last, and 
also its stability in water is very good. Quantification was 
FIGURE 2 - Capillary electrophoretic separation of AMX and CLA from mixture (experimental conditions: 25 mM sodium 
tetraborate BGE, pH – 9.30, voltage + 25 kV, temperature 25 oC, hydrodynamic injection 50 mbar/1 sec., sample concentration 
10 µg mL-1, UV detection 230 nm).
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accomplished on the basis of AMX respectively CLA to IS 
peak-area ratios (peak area of AMX-CLA/peak area of IS).
The  in t ra -day  (average  o f  6  consecu t ive 
measurements taken on the same day) and inter-day 
precision (average of 6 measurements during two days) 
at three different concentrations (5, 10, 20 µg mL-1) was 
also determined. Precision, expressed as relative standard 
deviations (RSD%), was high with stable migration times 
and good repeatability of peak areas for both analytes. Very 
similar migration times and peak areas were obtained; the 
RSD values of the migration times were smaller than 1%, 
while the precision of the response was slightly worse (but 
smaller than 2.5%). The day to day analyses showed better 
repeatability for AMX in comparison with CLA (Table I).
The individual linear regression equations for AMX 
and CLA were calculated according to six concentrations 
in a specific range (2.5 - 50 µg mL-1 for both analytes) and 
three replicates per concentration (Table I). The linear 
regression coefficients were always above 0.99.
The l imit  of  detection (LOD) and l imit  of 
quantification (LOQ) were estimated as: standard 
deviation of regression equation/slope of the regression 
equation multiplied by 3.3 and 10, respectively (Table I).
The robustness of the method was examined by 
making slight changes to the following parameters: buffer 
pH (9.0-9.3), buffer concentration (25-30 mM), applied 
voltage (22-25 kV) and injection pressure (40-50 mbar), 
taking into consideration the variation of migration 
times. The slight variation of these parameter does not 
significantly modify migration times (RSD <2.5%).
The accuracy of the method was determined by 
using recovery experiments analyzing solutions of 
known concentrations within the linearity range at three 
levels (10, 25 and 50 µg mL-1), the mean recovery was 
99.10% for CLA acid and 99.80% for AMX (n = 3 at each 
concentration level), respectively.
Specificity of the method was confirmed by addition 
of AMX and CLA reference substances to an Augmentin 
sample solution, only two distinct properly separated 
peaks were obtained.
The optimized procedure was applied to the analysis 
of AMX and CLA found in combined pharmaceutical 
preparations. Ten samples prepared from pharmaceutical 
formulations were analyzed, and three injections were 
done to obtain the average values of drug concentration. 
All the label claims were in the range of 95.5–101.5%, and 
the results were in agreement with the contents declared 
by the manufactures (Table II).
The peaks obtained from the samples prepared from 
tablets were very similar to those obtained from standard 
and there were no noticeable interferences from the matrix. 
It is important that tablet excipients do not interfere in the 
determination of the studied analytes, since they allow 
direct injections, thus involving minimum handling.
TABLE I - Analytical performance of the CZE separation
Parameter Amoxicillin Clavulanic acid
Day by day repeatability
RSD migration time (%) 0.33 0.41
RSD peak area (%) 0.97 1.12
Day to day repeatability
RSD migration time (%) 0.48 0.55
RSD peak area (%) 1.44 1.97
Linearity
Regression equation y= 0,474x + 0,9406 y= 0,5057x + 1,2639
Correlation coefficient 0.9980 0.9950
LOD (μg mL-1) 2.87 2.95
LOQ (μg mL-1) 8.69 8.95
TABLE II - Determination of active compounds from Augmentin 625 mg (500 mg AMX + 125 mg CLA)
Substance Declared quantities (mg) Found quantities (mg) RSD (%) SD (%)
AMX 500 496.44 0.38 0.92
CLA 125 123.35 0.24 1.88
RSD – relative standard deviation, SD – standard deviation
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CONCLUSION
Differences between electrophoretic behavior 
and mobility of AMX and CLA allow good separation 
and precise, simultaneous determination of the studied 
analytes using a simple and rapid CZE method.
There are a number of reports on simultaneous 
determination of AMX and CLA by HPLC methods, but, 
although these methods are selective and sensitive, they 
are not the most suitable for routine analytical analysis 
because of their special requirements and financial 
reasons. Compared with these previously published 
methods the advantages of our CE method are related to: 
fast analysis time, rapid method development, and low 
consumption of analytes and organic solvents.
The proposed technique can be successfully used for 
the simultaneous determination of AMX and CLA from 
combined pharmaceutical preparations.
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